313 related articles for article (PubMed ID: 34356618)
21. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel model of global forebrain ischaemia-reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke.
Lee NT; Selan C; Chia JSJ; Sturgeon SA; Wright DK; Zamani A; Pereira M; Nandurkar HH; Sashindranath M
Sci Rep; 2020 Oct; 10(1):18170. PubMed ID: 33097782
[TBL] [Abstract][Full Text] [Related]
23. Anti-endothelial cell antibodies in patients with cerebral small vessel disease.
Kimura A; Sakurai T; Yamada M; Koumura A; Hayashi Y; Tanaka Y; Hozumi I; Ohtaki H; Chousa M; Takemura M; Seishima M; Inuzuka T
Curr Neurovasc Res; 2012 Nov; 9(4):296-301. PubMed ID: 23030505
[TBL] [Abstract][Full Text] [Related]
24. LncRNA Snhg8 attenuates microglial inflammation response and blood-brain barrier damage in ischemic stroke through regulating miR-425-5p mediated SIRT1/NF-κB signaling.
Tian J; Liu Y; Wang Z; Zhang S; Yang Y; Zhu Y; Yang C
J Biochem Mol Toxicol; 2021 May; 35(5):e22724. PubMed ID: 33491845
[TBL] [Abstract][Full Text] [Related]
25. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
Front Immunol; 2020; 11():575890. PubMed ID: 33042158
[TBL] [Abstract][Full Text] [Related]
26. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
27. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
28. Emerging Role of Immunity in Cerebral Small Vessel Disease.
Fu Y; Yan Y
Front Immunol; 2018; 9():67. PubMed ID: 29422904
[TBL] [Abstract][Full Text] [Related]
29. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
Wang C; Yin Q; Su Z; Xia L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
31. Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells.
Burnstock G
Pharmacol Rep; 2008; 60(1):12-20. PubMed ID: 18276981
[TBL] [Abstract][Full Text] [Related]
32. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
[TBL] [Abstract][Full Text] [Related]
33. Hyperglycemia modulates redox, inflammatory and vasoactive markers through specific signaling pathways in cerebral endothelial cells: Insights on insulin protective action.
Arcambal A; Taïlé J; Rondeau P; Viranaïcken W; Meilhac O; Gonthier MP
Free Radic Biol Med; 2019 Jan; 130():59-70. PubMed ID: 30359759
[TBL] [Abstract][Full Text] [Related]
34. Purinergic signaling during intestinal inflammation.
Longhi MS; Moss A; Jiang ZG; Robson SC
J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
[TBL] [Abstract][Full Text] [Related]
35. Vascular inflammation in cerebral small vessel disease.
Rouhl RP; Damoiseaux JG; Lodder J; Theunissen RO; Knottnerus IL; Staals J; Henskens LH; Kroon AA; de Leeuw PW; Tervaert JW; van Oostenbrugge RJ
Neurobiol Aging; 2012 Aug; 33(8):1800-6. PubMed ID: 21601314
[TBL] [Abstract][Full Text] [Related]
36. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide metabolism and cell-cell interactions.
Eltzschig HK; Weissmüller T; Mager A; Eckle T
Methods Mol Biol; 2006; 341():73-87. PubMed ID: 16799190
[TBL] [Abstract][Full Text] [Related]
38. Modulation of vascular integrity and neuroinflammation by peroxiredoxin 4 following cerebral ischemia-reperfusion injury.
Yang J; Wang Z; Liu X; Lu P
Microvasc Res; 2021 May; 135():104144. PubMed ID: 33515567
[TBL] [Abstract][Full Text] [Related]
39. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Kraft P; Göb E; Schuhmann MK; Göbel K; Deppermann C; Thielmann I; Herrmann AM; Lorenz K; Brede M; Stoll G; Meuth SG; Nieswandt B; Pfeilschifter W; Kleinschnitz C
Stroke; 2013 Nov; 44(11):3202-10. PubMed ID: 24029635
[TBL] [Abstract][Full Text] [Related]
40. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
